🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🚨 BIG NEWS IN ANEURYSM TREATMENT! 🚨 The SCENT trial’s 5-year results are in, and the Surpass flow diverter is proving to be a game-changer for treating large or giant wide-neck aneurysms! 💉🧠 Highlights: ✅ 90.2% aneurysm occlusion rate at 5 years ✅ No new major ipsilateral

6 clinical trials. Level 1A recommendations. Are there really any doubts left.. SVIN #missionthrombectomy #worldthrombectomyday #strokeawarenessmonth

#STROKE Images: Endovascular OCT provides confirmation at a near-pathological level intraplaque hemorrhage. 🟠 #AHAJournals ahajrnls.org/3Zo6e19

🚨 BREAKTHROUGH IN SPINAL CSF LEAK TREATMENT! 🚨 A new study characterizes the intracranial shifts in volume in patients with spontaneous intracranial hypovolemia (SIH) after treatment. 🧠💉 Key Findings: ✅ Early increase in ventricular CSF volume ✅ Significant decrease in

Disgusting..

’Every surgeon carries within himself a small cemetery, where from time to time he goes to pray – a place of bitterness and regret, where he must look for an explanation for his failures.’ René Leriche, La philosophie 1951 #SecondVictimSyndrome SVIN SNIS Info

Alembic’s Ticagrelor Approval: A Strategic Move in the Generic Antiplatelet Market ainvest.com/news/alembic-t…

SummitMax results presented at #ESOC2025 showing improved revascularization and higher first pass effect of the HiPoint 88 aspiration device for EVT in ICA/M1 with similar safety. Thanh Nguyen 🇺🇦 👏 Stroke AHA/ASA

OPTIMIST trial shows borderline evidence that in acute stroke pts with NIHSS <10, less intense post lysis monitoring is non inferior to standard monitoring ⁦The Lancet⁩ ⁦European Stroke Org⁩ #ESOC2025

EscapeMeVo posthoc analysis suggesting treatment modification of time to treatment with potential benefit of EVT in pts treated within the 3-h time window #ESOC2025 presented by Michael Hill

Are permanent bilateral carotid filters useful for preventing stroke in high risk AF patients? Promising results presented by ⁦Ashkan Shoamanesh⁩ at #ESOC2025 Phase III trial is planned ⁦European Stroke Org⁩

Said it before and I’ll say it again: it’s not about #RadialFirst vs. #FemoralForever—it’s about #PatientFirst. As an early adopter, I converted to #neuroradialism several years ago—and have had little reason to look back. Gabor Toth, MD’s high-yield pearls and pitfalls

On the administrative side of developing/growing a Comprehensive Stroke Center, the emphasis on 24/7 subspecialty-trained staffing for both the NeuroICU and the Neurointerventional Suite remains paramount #stroke #medicaladministration neuronewsinternational.com/elevating-stro…

#ESOC2025 #ERASE_Stroke Edaravone (free radical scavenger) for neuroprotection in acute stroke 🇨🇳 💊initiated<24hr, for 28d 🎯1ry outcome: mRS </= 1 at 90d 307 pts each arm (~63yo, NIHSS 7) ✅Results: 65.4 vs 47.1% (OR 2.12, p<0.01) 🧐No ≠ NIHSS change 🩸No increase of sICH

#ESOC2025: In a retrospective observational cohort study drawing data from 66 sites, EVT was not associated with a lower level of disability than medical management among patients with M2 occlusion presenting in the 6-24h window poststroke symptom onset. ahajournals.org/doi/10.1161/ST…

The Rule of 26: In the SELECT-2 trial of EVT for large core LVO in which an overall benefit was seen, a large (>26 ml) core of severe hypodensity (<26 HU) negated the benefit of thrombectomy and was associated w/ an ⬆️ risk of hemicraniectomy ahajournals.org/doi/abs/10.116…

This is great! Need to look further into how it relates to the PICASSO trial

Them: "Medicaid needs to thrive." Centene is the largest Medicaid MCO in the United States. Wait till they find out what actually happens when "Medicaid thrives." (Remember, a neurosurgeon making $650k is "greedy.") Max Jordan Nguemeni Anthony DiGiorgio, DO, MHA

What if your direct-to-angio patient has ICH? My Editorial in Stroke AHA/ASA ahajournals.org/doi/10.1161/ST… Is one-stop treatment for ICH in the angio the futur Marios Psychogios Johannes Kaesmacher Thanh Nguyen 🇺🇦 Stroke Research Center Bern ? Great paper from David R-L and coleagues: ahajournals.org/doi/10.1161/ST…

Prepping my summary slide of #ESOC2025 for residents talk.. So much has happened ❤️🧠 ✨ #stroke #voiceofstroke